Flu vaccine package inserts
[back] Package inserts  [back] Flu vaccines

Package Inserts and Manufacturers for some US Licensed Vaccines and Immunoglobulins

FLULAVAL Vaccine 'Package Insert' Warning: Vaccine Not Demonstrated To Decrease Influenza, Associated With Many Serious Diseases by Jim West

[2010 Sept] Parallel Universes: Flu Shots For Pregnant Women

[2009 Oct] Mercury in 4 AH1N1 U.S. injectable vaccines: Fluarix, FLULAVAL, FLUVIRIN, Fluzone

[2009 pdf] Afluria
[2009 pdf] Fluarix  FLUARIX is formulated without preservatives. FLUARIX does not contain thimerosal. Each 0.5-mL dose also contains octoxynol-10 (TRITON® X-100) ≤0.085 mg, α-tocopheryl hydrogen succinate ≤0.1 mg, and polysorbate 80 (Tween 80) ≤0.415 mg. Each dose may also contain residual amounts of hydrocortisone ≤0.0016 mcg, gentamicin sulfate ≤0.15 mcg, ovalbumin ≤0.05 mcg, formaldehyde ≤5 mcg, and sodium deoxycholate ≤50 mcg from the manufacturing process.
[2009 pdf] Flulaval
[2009 pdf] Fluzone
[2009 pdf] Fluvirin
[pdf] CSL  Influenza A (H1N1) 2009 Monovalent Vaccine
[pdf] sanofi pasteur Influenza A (H1N1) 2009 Monovalent Vaccine
[pdf] Novartis Influenza A (H1N1) 2009 Monovalent Vaccine
[pdf] Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal Manufactured by MedImmune, LLC
FLULAVAL™ (Influenza Virus Vaccine)


Begrivac ® (Wyeth)

Fluarix ® (Glaxo SmithKline)

FLUVIRIN® (Evans Vaccine)


Influvac Sub-unit ® (Solvay Healthcare Ltd

Inactivated Influenza Vaccine (Split Virion) (Aventis Pasteur MSD Ltd

Inactivated Influenza Vaccine (Surface Antigen) (Evans Vaccine)

Fluvirin http://goodlight.net/nyvic/health/package.htm  

Fluviral (package insert)
Fluzone (package insert)  Connaught
Fluzone 2002-2003    Fluzone pdf

"Unlike the 1976-77 swine influenza vaccine, subsequent vaccines prepared from other virus strains have not been associated clearly with an increased frequency of Guillain-Barré syndrome (GBS). However, it is difficult to make a precise estimate of risk for a rare condition such as GBS. In 1990-91 in the United States, although there was no overall increase in frequency of GBS among vaccine recipients, there may have been a small increase in GBS cases in vaccinated persons 18 to 64 years of age, but not in those aged ³65 years. In contrast to the swine influenza vaccine, the epidemiologic features of the possible association of the 1990-91 vaccine with GBS were not as convincing. Even if GBS were a true side effect, the very low estimated risk for GBS is less than that of severe influenza that could be prevented by vaccine. Influenza vaccine is not known to predispose to Reye's syndrome.

Other neurologic illnesses, including facial paralysis, encephalitis, encephalopathy, demyelinating disease and labyrinthitis following influenza vaccination have been reported. Relationship to vaccine other than temporal has not been established.
Fatalities from a variety of other causes have been reported in the high-risk population following influenza vaccination without the establishment of a definite causal relationship."--FLUVIRAL

Influenza Virus Vaccine
Medeva Pharmaceuticals
produced using embryonic fluid (chicken egg), neomycin, polymyxin, thimerosal, betapropiolactone
medium: embryonic fluid (chicken egg)

Influenza Virus Vaccine, Trivalent, Types A&B
produced using gentamicin sulfate, formaldehyde, polysorbate 80, tri(n)butylphosphate, thimerosal
medium: chick embryos